If you made any changes in Pure these will be visible here soon.

Research Output

2019

Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the “Rete Ematologica Pugliese”

Di Renzo, N., Melillo, L., Porretto, F., Dargenio, M., Pavone, V., Pastore, D., Mazza, P., Mannina, D., Merenda, A., Cascavilla, N., Greco, G., Matera, R., Bonizzoni, E., Celio, L. & Musso, M., Jan 1 2019, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Open Access

Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: A meta-analysis of randomised evidence

Celio, L., Bonizzoni, E., Zattarin, E., Codega, P., De Braud, F. & Aapro, M., Dec 30 2019, In : BMC Cancer. 19, 1, 1268.

Research output: Contribution to journalArticle

Open Access

Neurokinin-1 receptor antagonists: review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults

Karthaus, M., Schiel, X., Ruhlmann, C. H. & Celio, L., Jul 3 2019, In : Expert Review of Clinical Pharmacology. 12, 7, p. 661-680 20 p.

Research output: Contribution to journalReview article

Open Access

One-Day Versus Three-Day Dexamethasone in Combination with Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Individual Patient Data-Based Meta-Analysis

Okada, Y., Oba, K., Furukawa, N., Kosaka, Y., Okita, K., Yuki, S., Komatsu, Y., Celio, L. & Aapro, M., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalReview article

Open Access

Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives

Vernieri, C., Milano, M., Brambilla, M., Mennitto, A., Maggi, C., Cona, M. S., Prisciandaro, M., Fabbroni, C., Celio, L., Mariani, G., Bianchi, G. V., Capri, G. & de Braud, F., Jul 2019, In : Critical Reviews in Oncology/Hematology. 139, p. 53-66 14 p.

Research output: Contribution to journalReview article

Short-course olanzapine to prevent delayed emesis following carboplatin/paclitaxel for gynecologic cancer: a randomised study

Celio, L., Saibene, G., Lepori, S., Festinese, F., Niger, M., Raspagliesi, F. & Lorusso, D., Jun 1 2019, In : Tumori. 105, 3, p. 253-258 6 p.

Research output: Contribution to journalArticle

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles

Vernieri, C., Prisciandaro, M., Milano, M., Cona, M. S., Maggi, C., Brambilla, M., Mennitto, A., Fabbroni, C., Farè, E., Cresta, S., Celio, L., Mariani, G., Bianchi, G., Capri, G. & de Braud, F., Apr 2019, In : Clinical Breast Cancer. 19, 2, p. e306-e318

Research output: Contribution to journalArticle

Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer

Giaccherini, C., Marchetti, M., Masci, G., Verzeroli, C., Russo, L., Celio, L., Sarmiento, R., Gamba, S., Tartari, C. J., Diani, E., Vignoli, A., Malighetti, P., Spinelli, D., Tondini, C., Barni, S., Giuliani, F., Petrelli, F., D'Alessio, A., Gasparini, G., De Braud, F. & 3 others, Santoro, A., Labianca, R. & Falanga, A., Sep 26 2019, In : Haematologica.

Research output: Contribution to journalArticle

2018

Pro-netupitant/palonosetron (IV) for the treatment of radio-and-chemotherapy-induced nausea and vomiting

Celio, L. & Fabbroni, C., Aug 2018, In : Expert Opinion on Pharmacotherapy. 19, 11, p. 1267-1277 11 p.

Research output: Contribution to journalArticle

2017

2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy

Herrstedt, J., Roila, F., Warr, D., Celio, L., Navari, R. M., Hesketh, P. J., Chan, A. & Aapro, M. S., Jan 1 2017, In : Supportive Care in Cancer. 25, 1, p. 277-288 12 p.

Research output: Contribution to journalArticle

Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy

Restelli, U., Saibene, G., Nardulli, P., DI Turi, R., Bonizzoni, E., Scolari, F., Perrone, T., Croce, D. & Celio, L., Jul 1 2017, In : BMJ Open. 7, 7, e015645.

Research output: Contribution to journalArticle

2016

Prevention of cinv in patients receiving high-dose multiple-day chemotherapy

Celio, L., Jan 1 2016, Management of Chemotherapy-Induced Nausea and Vomiting: New Agents and New Uses of Current Agents. Springer International Publishing, p. 135-156 22 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2015

Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: An evidence-based review of safety, efficacy, and place in therapy

Celio, L., Niger, M., Ricchini, F. & Agustoni, F., Aug 21 2015, In : Core Evidence. 10, p. 75-87 13 p.

Research output: Contribution to journalArticle

Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy

Mirabile, A., Celio, L., Magni, M., Bonizzoni, E., Gianni, A. M. & Di Nicola, M., Dec 1 2014, In : Future Oncology. 10, 16, p. 2569-2578 10 p.

Research output: Contribution to journalArticle

2013

Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? Analysis of a phase II trial

Damian, S., Celio, L., De Benedictis, E., Mariani, P., Agustoni, F., Ricchini, F. & De Braud, F., Jun 2013, In : Oncology. 84, 6, p. 371-377 7 p.

Research output: Contribution to journalArticle

Palonosetron plus dexamethasone in highly emetogenic chemotherapy: Pooled data from two Phase III trials

Celio, L., Agustoni, F., Ricchini, F., Dotti, K., Niger, M. & Braud, F. D., Oct 2013, In : Future Oncology. 9, 10, p. 1451-1458 8 p.

Research output: Contribution to journalArticle

Research on chemotherapy-induced nausea: Back to the past for an unmet need?

Celio, L. & Aapro, M., Apr 1 2013, In : Journal of Clinical Oncology. 31, 10, p. 1376-1377 2 p.

Research output: Contribution to journalArticle

2012

Palonosetron: An evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy

Celio, L., Agustoni, F., Testa, I., Dotti, K. & De Braud, F., May 2012, In : Tumori. 98, 3, p. 279-286 8 p.

Research output: Contribution to journalArticle

2011

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: A randomized, multicenter, phase III trial

Celio, L., Frustaci, S., Denaro, A., Buonadonna, A., Ardizzoia, A., Piazza, E., Fabi, A., Capobianco, A. M., Isa, L., Cavanna, L., Bertolini, A., Bichisao, E. & Bajetta, E., Aug 2011, In : Supportive Care in Cancer. 19, 8, p. 1217-1225 9 p.

Research output: Contribution to journalArticle

2009

Feasibility study of biweekly capecitabine, oxaliplatin, and irinotecan in patients with untreated advanced gastric cancer

Bajetta, E., Verzoni, E., Ferrario, E., Dotti, K., Gevorgyan, A. & Celio, L., Jan 2009, In : Tumori. 95, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: A multi-institutional phase II study

Celio, L., Sternberg, C. N., Labianca, R., La Torre, I., Amoroso, V., Barone, C., Pinotti, G., Cascinu, S., Di Costanzo, F., Cetto, G. L. & Bajetta, E., 2009, In : Annals of Oncology. 20, 6, p. 1062-1067 6 p.

Research output: Contribution to journalArticle

2008

Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting

Celio, L., Denaro, A., Canova, S., Gevorgyan, A. & Bajetta, E., Jul 2008, In : Tumori. 94, 4, p. 447-452 6 p.

Research output: Contribution to journalArticle

Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer

Cappelletti, V., Gariboldi, M., De Cecco, L., Toffanin, S., Reid, J. F., Lusa, L., Bajetta, E., Celio, L., Greco, M., Fabbri, A., Pierotti, M. A. & Daidone, M. G., Jun 2008, In : Endocrine-Related Cancer. 15, 2, p. 439-449 11 p.

Research output: Contribution to journalArticle

2007

Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer.

Bajetta, E., Celio, L., Ferrario, E., Di Bartolomeo, M., Denaro, A., Dotti, K., Mancin, M., Bajetta, R., Colombo, A. & Pusceddu, S., Nov 2007, In : Annals of Oncology. 18, 11, p. 1810-1816 7 p.

Research output: Contribution to journalArticle

2006

Neuroendocrine tumors of the larynx: A clinical report and literature review

Procopio, G., Ricotta, R., Fusi, A., Celio, L., De Dosso, S., Catena, L., Ferrari, L., Quattrone, P., Verzoni, E. & Bajetta, E., Jan 2006, In : Tumori. 92, 1, p. 72-75 4 p.

Research output: Contribution to journalArticle

2005

Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women

Bajetta, E., Procopio, G., Celio, L., Gattinoni, L., Della Torre, S., Mariani, L., Catena, L., Ricotta, R., Longarini, R., Zilembo, N. & Buzzoni, R., 2005, In : Journal of Clinical Oncology. 23, 10, p. 2155-2161 7 p.

Research output: Contribution to journalArticle

2004

Acute confusional state with fatal outcome in a cancer patient

Caraceni, A., Andreola, S., Simonetti, F. & Celio, L., Feb 2004, In : Neurological Sciences. 24, 6, p. 424-425 2 p.

Research output: Contribution to journalArticle

Prospective evaluation of estrogen receptor-β in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients

Cappelletti, V., Celio, L., Bajetta, E., Allevi, A., Longarini, R., Miodini, P., Villa, R., Fabbri, A., Mariani, L., Giovanazzi, R., Galante, E., Greco, M. & Daidone, M. G., Dec 2004, In : Endocrine-Related Cancer. 11, 4, p. 761-770 10 p.

Research output: Contribution to journalArticle

2003

Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?

Ferrari, L., Bajetta, E., Martinetti, A., Celio, L., Longarini, R., La Torre, I., Buzzoni, R., Gattinoni, L., Seregni, E. & Bombardieri, E., May 2003, In : International Journal of Oncology. 22, 5, p. 1081-1089 9 p.

Research output: Contribution to journalArticle

Phase II study of pemetrexed disodium (Alimta®) administered with oral folic acid in patients with advanced gastric cancer

Bajetta, E., Celio, L., Buzzoni, R., Ferrari, L., Marchianò, A., Martinetti, A., Longarini, R., Becerra, C., Ilardi, C. & John, W., Oct 2003, In : Annals of Oncology. 14, 10, p. 1543-1548 6 p.

Research output: Contribution to journalArticle

2002

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

Bajetta, E., Ferrari, L., Procopio, G., Catena, L., Ferrario, E., Martinetti, A., Di Bartolomeo, M., Buzzoni, R., Celio, L., Vitali, M., Beretta, E., Seregni, E. & Bombardieri, E., 2002, In : Annals of Oncology. 13, 4, p. 614-621 8 p.

Research output: Contribution to journalArticle

Pemetrexed in gastric cancer: Clinical experience and future perspectives

Celio, L., Buzzoni, R., Longarini, R., Marchianò, A. & Bajetta, E., Dec 2002, In : Seminars in Oncology. 29, 6 SUPPL. 18, p. 63-68 6 p.

Research output: Contribution to journalArticle

Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients

Ferrari, L., Martinetti, A., Zilembo, N., Pozzi, P., Buzzoni, R., La Torre, I., Gattinoni, L., Catena, L., Vitali, M., Celio, L., Seregni, E., Bombardieri, E. & Bajetta, E., 2002, In : Journal of Steroid Biochemistry and Molecular Biology. 80, 4-5, p. 411-418 8 p.

Research output: Contribution to journalArticle

2000

Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: A phase II trial

Lønning, P. E., Bajetta, E., Murray, R., Tubiana-Hulin, M., Eisenberg, P. D., Mickiewicz, E., Celio, L., Pitt, P., Mita, M., Aaronson, N. K., Fowst, C., Arkhipov, A., Salle, E. D., Polli, A. & Massimini, G., Jun 2000, In : Journal of Clinical Oncology. 18, 11, p. 2234-2244 11 p.

Research output: Contribution to journalArticle

Adjuvant oophorectomy versus CMF in premenopausal node-positive breast cancer: Long-term results of an experience at the Milan Cancer Institute

Salvadori, B., Celio, L., Oriana, R. & Bajetta, E., May 2000, In : Tumori. 86, 3, p. 258-259 2 p.

Research output: Contribution to journalArticle

New clinical trials for the treatment of neuroendocrine tumors

Bajetta, E., Bichisao, E., Artale, S., Celio, L., Ferrari, L., Di Bartolomeo, M., Zilembo, N., Stani, S. C. & Buzzoni, R., 2000, In : Quarterly Journal of Nuclear Medicine. 44, 1, p. 96-101 6 p.

Research output: Contribution to journalArticle

Ovarian ablation for premenopausal early-stage breast cancer: An update

Celio, L., Bajetta, E., Toffolatti, L., Catena, L., Beretta, E. & Buzzoni, R., May 2000, In : Tumori. 86, 3, p. 191-194 4 p.

Research output: Contribution to journalArticle

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors

Bajetta, E., Zilembo, N., Bichisao, E., Martinetti, A., Buzzoni, R., Pozzi, P., Bidoli, P., Ferrari, L. & Celio, L., 2000, In : Annals of Oncology. 11, 8, p. 1017-1022 6 p.

Research output: Contribution to journalArticle

1999

Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

Bajetta, E., Ferrari, L., Martinetti, A., Celio, L., Procopio, G., Artale, S., Zilembo, N., Di Bartolomeo, M., Seregni, E. & Bombardieri, E., Sep 1 1999, In : Cancer. 86, 5, p. 858-865 8 p.

Research output: Contribution to journalArticle

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients

Bajetta, E., Zilembo, N., Dowsett, M., Guillevin, L., Di Leo, A., Celio, L., Martinetti, A., Marchianò, A., Pozzi, P., Stani, S. & Bichisao, E., Feb 1999, In : European Journal of Cancer. 35, 2, p. 208-213 6 p.

Research output: Contribution to journalArticle

Fluoropyrimidines in the treatment of advanced neoplastic diseases: Role and advantages of UFT

Del Vecchio, M., Procopio, G., Cassata, A., Pozzi, P., Busto, G., Celio, L. & Bajetta, E., Jan 1999, In : Tumori. 85, 1, p. 6-11 6 p.

Research output: Contribution to journalArticle

1998

Effects of short-term pre-operative tamoxifen on steroid receptor and Ki-67 expression in primary breast cancer: An immunocytochemical study

Bajetta, E., Celio, L., Di Leo, A., Bartoli, C., Pilotti, S., Leutner, M., Bono, A., Ferrari, L., Buzzoni, R., Zilembo, N., De Candis, D. & Moglia, D., Apr 1998, In : International Journal of Oncology. 12, 4, p. 853-858 6 p.

Research output: Contribution to journalArticle